Tag: EC Column
Two investors weigh in: Is your SPAC just a PIPE dream?
Hope Cochran Contributor Hope Cochran is an investor at Madrona Venture Group, where she invests in early-stage fintech and ML/AI applications for the business environment. Ishani Ummat Contributor Ishani Ummat is an investor at Madrona Venture Group who focuses on sourcing and evaluating new investment opportunities, as well as supporting…
Read More
2021 should be a banner year for biotech startups that make smart choices early
Michael B. Gray Contributor Michael B. Gray is partner and leader of the private equity, venture capital and growth companies practice, Neal Gerber Eisenberg. John Flavin Contributor Last year was a record 12 months for venture-backed biotech and pharma companies, with deal activity rising to $28.5 billion from $17.8 billion…
Read More
To sell or not to sell: Lessons from a bootstrapped CEO
Glen Rabie Contributor Glen Rabie is co-founder and CEO of Yellowfin, a global analytics and BI software vendor. The clock begins ticking on a startup the day the doors open. Regardless of a young company’s struggles or success, sooner or later the question of when, how or whether to sell…
Read More
Business continuity planning is a necessity for your fund and portfolio
Will Poole Contributor Will Poole is co-founder and managing partner of Capria Ventures, a global financial services firm leading, partnering with and funding the largest network of fund managers collaborating to deliver superior returns and scaled impact in emerging markets. Just shy of a year ago, I sent an email…
Read More
Data scientists: Bring the narrative to the forefront
Peter Wang Contributor Peter Wang is CEO and co-founder of data science platform Anaconda. He’s also a co-creator of the PyData community and conferences, and a member of the board at the Center for Humane Technology. By 2025, 463 exabytes of data will be created each day, according to some…
Read More
Enterprise security attackers are one password away from your worst day
Ralph Pisani Contributor Ralph Pisani is president at Exabeam and has 20 years of experience in sales and channel and business development at organizations like Imperva and SecureComputing (acquired by McAfee). If the definition of insanity is doing the same thing over and over and expecting a different outcome, then…
Read More